Variant report
Variant | nsv819571 |
---|---|
Chromosome Location | chr10:45674729-45678703 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3)
- CpG islands (count:184)
- Chromatin interactive region (count:5)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:3 , 50 per page) page:
1
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:45675633-45675683 | NT2-D1 | testis: | n/a |
2 | chr10:45675633-45675683 | NT2-D1 | testis: | n/a |
3 | chr10:45675680-45675730 | NHBE | bronchial: | n/a |
4 | chr10:45675577-45675627 | SAEC | small airway: | n/a |
5 | chr10:45675633-45675683 | GM12891 | blood: | n/a |
6 | chr10:45675633-45675683 | HCT-116 | colon: | n/a |
7 | chr10:45675577-45675627 | BJ | skin: | n/a |
8 | chr10:45675633-45675683 | HCPEpiC | choroid plexus: | n/a |
9 | chr10:45675577-45675627 | SKMC | muscle: | n/a |
10 | chr10:45675577-45675627 | U87 | brain: | n/a |
11 | chr10:45675680-45675730 | RPTEC | kidney: | n/a |
12 | chr10:45675680-45675730 | SAEC | small airway: | n/a |
13 | chr10:45675680-45675730 | HRCEpiC | kidney: | n/a |
14 | chr10:45675577-45675627 | AG10803 | skin: | n/a |
15 | chr10:45675633-45675683 | A549 | lung: | n/a |
16 | chr10:45675577-45675627 | Hepatocyte | liver: | n/a |
17 | chr10:45675680-45675730 | HMEC | breast: | n/a |
18 | chr10:45675680-45675730 | H1-hESC | embryonic stem cell: | embryo |
19 | chr10:45675577-45675627 | CMK | blood: | n/a |
20 | chr10:45675680-45675730 | AoSMC | blood vessel: | n/a |
21 | chr10:45675680-45675730 | ovcar-3 | ovarian: | n/a |
22 | chr10:45675680-45675730 | K562 | blood: | n/a |
23 | chr10:45675633-45675683 | PFSK-1 | brain: | n/a |
24 | chr10:45675577-45675627 | LNCaP | prostate: | n/a |
25 | chr10:45675680-45675730 | HPAEpiC | pulmonary alveolar: | n/a |
26 | chr10:45675680-45675730 | HCF | heart: | n/a |
27 | chr10:45675633-45675683 | RPTEC | kidney: | n/a |
28 | chr10:45675680-45675730 | CMK | blood: | n/a |
29 | chr10:45675577-45675627 | HNPCEpiC | eye: | n/a |
30 | chr10:45675633-45675683 | NH-A | brain: | n/a |
31 | chr10:45675577-45675627 | SK-N-SH | brain: | n/a |
32 | chr10:45675577-45675627 | PrEC | prostate: | n/a |
33 | chr10:45675577-45675627 | HL-60 | blood: | n/a |
34 | chr10:45675680-45675730 | NB4 | blood: | n/a |
35 | chr10:45675577-45675627 | PFSK-1 | brain: | n/a |
36 | chr10:45675577-45675627 | AG04449 | skin: | fetal |
37 | chr10:45675577-45675627 | HRPEpiC | eye: | n/a |
38 | chr10:45675680-45675730 | HCPEpiC | choroid plexus: | n/a |
39 | chr10:45675577-45675627 | HCM | heart: | n/a |
40 | chr10:45675577-45675627 | HMEC | breast: | n/a |
41 | chr10:45675633-45675683 | GM19239 | blood: | n/a |
42 | chr10:45675680-45675730 | BE2_C | brain: | n/a |
43 | chr10:45675577-45675627 | NT2-D1 | testis: | n/a |
44 | chr10:45675633-45675683 | HEEpiC | esophagus: | n/a |
45 | chr10:45675680-45675730 | T-47D | breast: | n/a |
46 | chr10:45675633-45675683 | MCF10A-Er-Src | breast: | n/a |
47 | chr10:45675680-45675730 | HCM | heart: | n/a |
48 | chr10:45675680-45675730 | NHDF-neo | bronchial: | n/a |
49 | chr10:45675680-45675730 | HEEpiC | esophagus: | n/a |
50 | chr10:45675633-45675683 | AG10803 | skin: | n/a |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:45673653..45675477-chr10:45677321..45679221,2 | K562 | blood: | |
2 | chr10:45674490..45676456-chr10:45679865..45681519,2 | K562 | blood: | |
3 | chr10:45673165..45677202-chr10:45678075..45681365,4 | K562 | blood: | |
4 | chr10:45494680..45497168-chr10:45675442..45677371,2 | K562 | blood: | |
5 | chr10:45673653..45675477-chr10:45677321..45679221,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-OR13A1-1 | chr10:45676530-45676875 | ENSG00000227683 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000227683 | TF binding region |
ENSG00000227683 | CpG island |
ENSG00000165512 | chromatin interactions |
ENSG00000165511 | chromatin interactions |
ENSG00000227683 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs558555075 | chr10:45674807-45674808 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs560513024 | chr10:45674812-45674813 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs565655143 | chr10:45674816-45674817 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs112519872 | chr10:45674823-45674824 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191724935 | chr10:45674876-45674877 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs552684634 | chr10:45674910-45674911 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs12783369 | chr10:45675009-45675010 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs544306976 | chr10:45675027-45675028 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs570873198 | chr10:45675035-45675036 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs375773188 | chr10:45675038-45675039 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563898591 | chr10:45675055-45675056 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs145488041 | chr10:45675064-45675065 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs183891767 | chr10:45675103-45675104 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs148441720 | chr10:45675104-45675105 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs575903137 | chr10:45675109-45675110 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs11239374 | chr10:45675153-45675154 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs187569066 | chr10:45675238-45675239 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533662554 | chr10:45675283-45675284 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs368455597 | chr10:45675355-45675356 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs558197389 | chr10:45675357-45675358 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs368311759 | chr10:45675361-45675362 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs576441074 | chr10:45675373-45675374 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs191446496 | chr10:45675408-45675409 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs112227130 | chr10:45675420-45675421 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs143984680 | chr10:45675434-45675435 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs554914245 | chr10:45675487-45675488 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs574741926 | chr10:45675491-45675492 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs561435662 | chr10:45675498-45675499 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs372645364 | chr10:45675500-45675501 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs11239375 | chr10:45675525-45675526 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs542145455 | chr10:45675548-45675549 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs372016391 | chr10:45675563-45675564 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs113089551 | chr10:45675616-45675617 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs527860911 | chr10:45675625-45675626 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs552711489 | chr10:45675633-45675634 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs369003624 | chr10:45675643-45675644 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs564523099 | chr10:45675647-45675648 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs141089476 | chr10:45675679-45675680 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs550189080 | chr10:45675681-45675682 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs576515701 | chr10:45675711-45675712 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs568346638 | chr10:45675727-45675728 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs372496871 | chr10:45675744-45675745 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs534457731 | chr10:45675746-45675747 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs113905832 | chr10:45675765-45675766 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs60042454 | chr10:45675794-45675795 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs548155858 | chr10:45675835-45675836 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs566675965 | chr10:45675857-45675858 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs533700122 | chr10:45675883-45675884 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs558234203 | chr10:45675935-45675936 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs570259547 | chr10:45675953-45675954 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Mental retardation | 21062444 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 22241247 | CNVD |
Intellectual disability | 21811512 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Obesity | 21956041 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Breast cancer | 21785460 | CNVD |
Developmental delay | 21948486 | CNVD |
Dysmorphic features | 21948486 | CNVD |
Epilepsy | 21948486 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Autism | 19287141 | CNVD |
Intellectual disability | 21948486 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:45671600-45676200 | Weak transcription | Placenta | Placenta |
2 | chr10:45671600-45676400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr10:45674400-45675200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr10:45675000-45675200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr10:45675200-45675600 | Enhancers | Fetal Stomach | stomach |
6 | chr10:45675200-45676600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr10:45675400-45675600 | Enhancers | Adipose Nuclei | Adipose |
8 | chr10:45675400-45677200 | Enhancers | Fetal Muscle Leg | muscle |
9 | chr10:45676000-45676200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr10:45676000-45676600 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
11 | chr10:45676000-45676600 | Enhancers | Spleen | Spleen |
12 | chr10:45676000-45677200 | Enhancers | Aorta | Aorta |
13 | chr10:45676200-45676400 | Enhancers | Right Atrium | heart |
14 | chr10:45676200-45677600 | Enhancers | Placenta | Placenta |
15 | chr10:45676200-45679400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
16 | chr10:45676400-45677000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
17 | chr10:45676400-45677000 | Weak transcription | Right Atrium | heart |
18 | chr10:45676400-45677400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
19 | chr10:45676600-45677200 | Enhancers | Adipose Nuclei | Adipose |
20 | chr10:45676600-45677600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
21 | chr10:45676800-45677400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |